Patents/Inventors

Tilman Schlothauer

PenzbergDE17 patents

16 Patents

US126066142026
Human Fcrn-binding Modified Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US125961202026
Ph-gradient Spr-based Binding Assay
Hoffmann-la Roche Inc.
0 cites
US124668722025
Method for the Generation of an FCRN Expressing Cell by Targeted Integration of Multiple Expression Cassettes in a Defined Organization
Hoffmann-la Roche Inc.
0 cites
US124611092025
Vitro Prediction of in Vivo Half-life
Hoffmann-la Roche Inc.
0 cites
US123982032025
Method for Producing Bispecific Antibodies Comprising a Y436A Fc-region Mutation for Improved Protein A-binding
Hoffmann-la Roche Inc.
0 cites
US123917572025
Bispecific Antibodies Specific for PD1 and TIM3
Hoffmann-la Roche Inc.
0 cites
US122972632025
Humanized Anti-tau(ps422) Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US122641962025
Fc-receptor Binding Modified Asymmetric Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US122525332025
Anti-transferrin Receptor Antibodies with Tailored Affinity
Hoffmann-la Roche Inc.
0 cites
US122151522025
Humanized Anti-human CD19 Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US121039672024
Bispecific Anti-ccl2 Antibodies
Hoffmann-la Roche Inc.
0 cites
US118144092023
Fc-receptor Based Affinity Chromatography
0 cites
US117391422023
Bispecific Anti-ccl2 Antibodies
Hoffmann-la Roche Inc.
0 cites
US115847932023
Anti-transferrin Receptor Antibodies with Tailored Affinity
Hoffmann-la Roche Inc.
0 cites
US115724042023
Humanized Anti-tau(ps422) Antibodies and Methods of Use
Hoffman-la Rocher Inc.
0 cites
US115550672023
Fc-region Variants with Improved Protein A-binding
Hoffmann-la Roche Inc.
0 cites